215 related articles for article (PubMed ID: 31864665)
21. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
[TBL] [Abstract][Full Text] [Related]
22. Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy.
Panje C; Andratschke N; Brunner TB; Niyazi M; Guckenberger M
Strahlenther Onkol; 2016 Dec; 192(12):875-885. PubMed ID: 27778052
[TBL] [Abstract][Full Text] [Related]
23. Immune modulation by hypofractionated stereotactic radiation therapy: Therapeutic implications.
Popp I; Grosu AL; Niedermann G; Duda DG
Radiother Oncol; 2016 Aug; 120(2):185-94. PubMed ID: 27495145
[TBL] [Abstract][Full Text] [Related]
24. [Extracranial stereotactic radiotherapy for early-stage non-small cell lung cancer and oligometastases].
Riesterer O
Praxis (Bern 1994); 2013 Oct; 102(21):1309-16. PubMed ID: 24129299
[TBL] [Abstract][Full Text] [Related]
25. Fractionated stereotactic radiation therapy for adrenal metastases: contributing to local tumor control with low toxicity.
Burjakow K; Fietkau R; Putz F; Achterberg N; Lettmaier S; Knippen S
Strahlenther Onkol; 2019 Mar; 195(3):236-245. PubMed ID: 30374590
[TBL] [Abstract][Full Text] [Related]
26. A survey of the practice of stereotactic body radiotherapy for hepatocellular and pancreatic malignancies in India.
Lewis S; Chopra S; Singh R; Engineer R
Indian J Cancer; 2021; 58(4):532-538. PubMed ID: 33753598
[TBL] [Abstract][Full Text] [Related]
27. Current uses and applications of stereotactic body radiation therapy.
Ramos-Prudencio R; Lozano-Ruiz F; Rodríguez-Laguna A; Poitevin-Chacón MA
Gac Med Mex; 2023; 159(3):262-269. PubMed ID: 37494714
[TBL] [Abstract][Full Text] [Related]
28. Overview of stereotactic body radiotherapy and the nursing role.
Smink KA; Schneider SM
Clin J Oncol Nurs; 2008 Dec; 12(6):889-93. PubMed ID: 19064382
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic body radiotherapy for second primary lung cancer and intra-parenchymal lung metastasis in patients previously treated with surgery: evaluation of indications and predictors of decreased respiratory function.
Ishihara T; Yamada K; Harada A; Yukiue H; Tanahashi M; Niwa H; Matsui T; Yokomura K; Ejima Y; Sasaki R
Acta Oncol; 2018 Sep; 57(9):1232-1239. PubMed ID: 29722594
[TBL] [Abstract][Full Text] [Related]
30. Advances in external beam stereotactic body radiotherapy: principle concerns in implementing a liver radiation program.
Gaede S; Lock MI
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S13. PubMed ID: 28917251
[TBL] [Abstract][Full Text] [Related]
31. Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy.
Milano MT; Zhang H; Metcalfe SK; Muhs AG; Okunieff P
Breast Cancer Res Treat; 2009 Jun; 115(3):601-8. PubMed ID: 18719992
[TBL] [Abstract][Full Text] [Related]
32. [Stereotactic radiotherapy of stage I non-small cell lung cancer. State of the art in 2019 and recommendations: Stereotaxy as an alternative to surgery?].
Kaiss H; Mornex F
Cancer Radiother; 2019 Oct; 23(6-7):720-731. PubMed ID: 31471255
[TBL] [Abstract][Full Text] [Related]
33. Emerging technologies in stereotactic body radiotherapy.
Ma L; Wang L; Tseng CL; Sahgal A
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S12. PubMed ID: 28917250
[TBL] [Abstract][Full Text] [Related]
34. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases.
Kavanagh BD; McGarry RC; Timmerman RD
Semin Radiat Oncol; 2006 Apr; 16(2):77-84. PubMed ID: 16564443
[TBL] [Abstract][Full Text] [Related]
35. Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency.
Nagata Y; Wulf J; Lax I; Timmerman R; Zimmermann F; Stojkovski I; Jeremic B
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):660-9. PubMed ID: 21281896
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis.
Shui Y; Yu W; Ren X; Guo Y; Xu J; Ma T; Zhang B; Wu J; Li Q; Hu Q; Shen L; Bai X; Liang T; Wei Q
Radiat Oncol; 2018 Sep; 13(1):188. PubMed ID: 30253783
[TBL] [Abstract][Full Text] [Related]
37. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation.
Hodge W; Tomé WA; Jaradat HA; Orton NP; Khuntia D; Traynor A; Weigel T; Mehta MP
Acta Oncol; 2006; 45(7):890-6. PubMed ID: 16982555
[TBL] [Abstract][Full Text] [Related]
38. Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer.
Britschgi C; Riesterer O; Burger IA; Guckenberger M; Curioni-Fontecedro A
Radiat Oncol; 2018 May; 13(1):102. PubMed ID: 29855323
[TBL] [Abstract][Full Text] [Related]
39. Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment.
Nabavizadeh N; Waller JG; Fain R; Chen Y; Degnin CR; Elliott DA; Mullins BT; Patel IA; Dyer BA; Fakhoury K; Naugler WE; Farsad K; Tanyi JA; Fuss M; Thomas CR; Hung AY
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):577-585. PubMed ID: 29413273
[TBL] [Abstract][Full Text] [Related]
40. Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study.
Burkon P; Kazda T; Pospisil P; Slavik M; Kominek L; Selingerova I; Blakaj DM; Prochazka T; Vrzal M; Rehak Z; Slampa P
Neoplasma; 2019 Mar; 66(2):315-325. PubMed ID: 30509112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
